Bibliography
- Perez-Severiano F, Santamaria A, Pedraza-Chaverri J, et al. Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation. Neurochem Res 2004;29(4):729-33
- Perry JJ, Fan L, Tainer JA. Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair. Neuroscience 2007;145(4):1280-99
- Jiang H, Jiang Q, Liu W, Feng J. Parkin suppresses the expression of monoamine oxidases. J Biol Chem 2006;281(13):8591-9
- Pratico D, Uryu K, Leight S, et al. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001;21(12):4183-7
- Xu J, Kao SY, Lee FJ, et al. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 2002;8(6):600-6
- Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60(8):759-67
- Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290(5806):457-65
- Villani G, Attardi G. In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells. Proc Natl Acad Sci USA 1997;94(4):1166-71
- Palmer G. Current issues in the chemistry of cytochrome c oxidase. J Bioenerg Biomembr 1993;25(2):145-51
- Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004;95(10):957-70
- Rodriguez M, Lucchesi BR, Schaper J. Apoptosis in myocardial infarction. Ann Med 2002;34(6):470-9
- Malecki MT. Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract 2005;68(Suppl1):S10-21
- Silva JP, Kohler M, Graff C, et al. Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet 2000;26(3):336-40
- Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1992;1(1):11-5
- Ballinger SW, Shoffner JM, Gebhart S, et al. Mitochondrial diabetes revisited. Nat Genet 1994;7(4):458-9
- Pulkes T, Hanna MG. Human mitochondrial DNA diseases. Adv Drug Deliv Rev 2001;49(1-2):27-43
- Wallace DC, Lott MT, Shoffner JM, Brown MD. Diseases resulting from mitochondrial DNA point mutations. J Inherit Metab Dis 1992;15(4):472-9
- Mukhopadhyay A, Weiner H. Delivery of drugs and macromolecules to mitochondria. Adv Drug Deliv Rev 2007;59(8):729-38
- Vestweber D, Schatz G. DNA-protein conjugates can enter mitochondria via the protein import pathway. Nature 1989;338(6211):170-2
- Seibel P, Trappe J, Villani G, et al. Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res 1995;23(1):10-7
- D'Souza GG, Boddapati SV, Weissig V. Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion 2005;5(5):352-8
- Chinnery PF, Taylor RW, Diekert K, et al. Peptide nucleic acid and delivery to human mitochondria. Gene Ther 2000;7(9):813
- Chinnery PF, Taylor RW, Diekert K, et al. Peptide nucleic acid delivery to human mitochondria. Gene Ther 1999;6(12):1919-28
- Rottenberg H. Membrane potential and surface potential in mitochondria: uptake and binding of lipophilic cations. J Membr Biol 1984;81(2):127-38
- Kelso GF, Porteous CM, Coulter CV, et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 2001;276(7):4588-96
- Adlam VJ, Harrison JC, Porteous CM, et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005;19(9):1088-95
- James AM, Sharpley MS, Manas AR, et al. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem 2007;282(20):14708-18
- Muratovska A, Lightowlers RN, Taylor RW, et al. Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res 2001;29(9):1852-63
- Ross GF, Smith PM, McGregor A, et al. Synthesis of trifunctional PNA-benzophenone derivatives for mitochondrial targeting, selective DNA binding, and photo-crosslinking. Bioconjug Chem 2003;14(5):962-6
- Koulintchenko M, Temperley RJ, Mason PA, et al. Natural competence of mammalian mitochondria allows the molecular investigation of mitochondrial gene expression. Hum Mol Genet 2006;15(1):143-54
- Enriquez JA, Chomyn A, Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat Genet 1995;10(1):47-55
- Kirino Y, Yasukawa T, Ohta S, et al. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci USA 2004;101(42):15070-5
- Kirino Y, Goto Y, Campos Y, et al. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc Natl Acad Sci USA 2005;102(20):7127-32
- Tarassov I, Entelis N, Martin RP. Mitochondrial import of a cytoplasmic lysine-tRNA in yeast is mediated by cooperation of cytoplasmic and mitochondrial lysyl-tRNA synthetases. EMBO J 1995;14(14):3461-71
- Entelis NS, Kieffer S, Kolesnikova OA, et al. Structural requirements of tRNALys for its import into yeast mitochondria. Proc Natl Acad Sci USA 1998;95(6):2838-43
- Entelis NS, Kolesnikova OA, Martin RP, Tarassov IA. RNA delivery into mitochondria. Adv Drug Deliv Rev 2001;49(1-2):199-215
- Kolesnikova OA, Entelis NS, Mireau H, et al. Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm. Science 2000;289(5486):1931-3
- Entelis NS, Kolesnikova OA, Dogan S, et al. 5 S rRNA and tRNA import into human mitochondria. Comparison of in vitro requirements. J Biol Chem 2001;276(49):45642-5
- Kolesnikova OA, Entelis NS, Jacquin-Becker C, et al. Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells. Hum Mol Genet 2004;3(20)2519-34
- Goswami S, Dhar G, Mukherjee S, et al. A bifunctional tRNA import receptor from Leishmania mitochondria. Proc Natl Acad Sci USA 2006;103(22):8354-9
- Mukherjee S, Basu S, Home P, et al. Necessary and sufficient factors for the import of transfer RNA into the kinetoplast mitochondrion. EMBO Rep 2007;8(6):589-95
- Mahata B, Bhattacharyya SN, Mukherjee S, Adhya S. Correction of translational defects in patient-derived mutant mitochondria by complex-mediated import of a cytoplasmic tRNA. J Biol Chem 2005;280(7):5141-4
- Mahata B, Mukherjee S, Mishra S, et al. Functional delivery of a cytosolic tRNA into mutant mitochondria of human cells. Science 2006;314(5798):471-4
- Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 2002;54(1):101-27
- Smith RA, Porteous CM, Gane AM, Murphy MP. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA 2003;100(9):5407-12
- Weissig V, Torchilin VP. Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems. Adv Drug Deliv Rev 2001;49(1-2):127-49
- Ross MF, Filipovska A, Smith RA, et al. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers. Biochem J 2004;383(Pt. 3):457-68
- Lee M, Choi JS, Choi MJ, et al. DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyehtylenimine. J Drug Target 2007;15:115-22
- Choi JS, Choi MJ, Ko KS, et al. Low molecular weight polyethylenimine-mitochondrial leader peptide conjugate for DNA delivery to mitochondria. Bull Kor Chem Soc 2006;27(9):1335-40
- Kang HC, Lee M, Bae YH. Polymeric gene carriers. Crit Rev Eukaryot Gene Expr 2005;15(4):317-42
- Lee M, Kim SW. Polymeric gene carriers. Pharm News 2002;9:407-15
- Han S, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Mol Ther 2000;2(4):302-17
- Moghimi SM, Symonds P, Murray JC, et al. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 2005;11(6):990-5
- Lee M, Rentz J, Han SO, et al. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther 2003;10(7):585-93
- Read ML, Bremner KH, Oupicky D, et al. Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J Gene Med 2003;5(3):232-45
- Heggeness MH, Simon M, Singer SJ. Association of mitochondria with microtubules in cultured cells. Proc Natl Acad Sci USA 1978;75(8):3863-6
- Steiber A, Kerner J, Hoppel CL. Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 2004;25(5-6):455-73
- Bigger BW, Tolmachov O, Collombet JM, et al. An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem 2001;276(25):23018-27
- Darquet AM, Rangara R, Kreiss P, et al. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther 1999;6(2):209-18
- Darquet AM, Cameron B, Wils P, et al. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther 1997;4(12):1341-9